GCXZ

One year net survival for men diagnosed between 2007 and 2011 and followed up to 2012

Testis – 98.1 per cent

Melanoma of skin – 96 per cent

Prostate – 93.1 per cent

Hodgkin lymphoma – 90.3 per cent

Larynx – 85 per cent

Rectum – 79.9 per cent

Bladder – 78 per cent

Non-Hodgkin lymphoma – 77.4 per cent

Colorectum – 75.9 per cent

Myeloma – 73.9 per cent

Colon – 73.8 per cent

Kidney – 72.9 per cent

Leukaemia – 67.1 per cent

Stomach – 43.7 per cent

Brain – 43.5 per cent

Oesophagus – 42.3 per cent

Lung – 31 per cent

Pancreas – 18.8 per cent

One year net survival for women diagnosed between 2007 and 2011 and followed up to 2012

Melanoma of skin – 97.9 per cent

Breast – 95.8 per cent

Hodgkin lymphoma – 93 per cent

Uterus – 89.9 per cent

Cervix – 83.7 per cent

Non-Hodgkin lymphoma – 80.1 per cent

Rectum – 79.4 per cent

Colorectum – 74.7 per cent

Myeloma – 74.7 per cent

Ovary – 73.7 per cent

Kidney – 73.2 per cent

Colon – 73 per cent

Bladder – 67.2 per cent

Leukaemia – 65 per cent

Brain – 44.1 per cent

Stomach – 42.2 per cent

Oesaphagus – 42.2 per cent

Lung – 35.4 per cent

Pancreas – 20.7 per cent

Five-year net survival for men diagnosed between 2007 and 2011 and followed up to 2012

Testis – 97.1 per cent

Melanoma of skin – 85.5 per cent

Hodgkin lymphoma – 82.4 per cent

Prostate – 81.7 per cent

Larynx – 66.1 per cent

Non-Hodgkin lymphoma – 62.4 per cent

Bladder – 58.6 per cent

Rectum – 57.1 per cent

Colon – 56.6 per cent

Colorectum – 56.5 per cent

Kidney – 54.7 per cent

Leukaemia – 47 per cent

Myeloma – 42.8 per cent

Stomach – 18.4 per cent

Brain – 17.8 per cent

Oesophagus – 13.5 per cent

Lung – 9.7 per cent

Pancreas – 4.7 per cent

Five-year net survival for women diagnosed between 2007 and 2011 and followed up to 2012

Melanoma of skin – 92.1 per cent

Hodgkin lymphoma – 86 per cent

Breast – 85 per cent

Uterus – 77.4 per cent

Non-Hodgkin lymphoma – 68.5 per cent

Cervix – 67.3 per cent

Rectum – 59.9 per cent

Colorectum – 57.8 per cent

Colon – 57.3 per cent

Kidney – 56.9 per cent

Bladder – 49.1 per cent

Leukaemia – 46.8 per cent

Ovary – 46.3 per cent

Myeloma – 41.6 per cent

Brain – 20.4 per cent

Stomach – 19.6 per cent

Oesaphagus – 15.6 per cent

Lung – 12.5 per cent

Pancreas – 5.4 per cent